Trond Mohn Research Foundation
Overview
Trond Mohn Research Foundation is a Norwegian non-profit foundation that supports research and research-promoting activities at the University of Bergen, Haukeland University Hospital, and other Norwegian research institutions, while also selectively investing in early-stage life science companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Pluvia Biotech | Mar 2017 | Seed | Co-investor |
| APIM Therapeutics AS | Dec 2017 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Trond Mohn Research Foundation based?
Trond Mohn Research Foundation is headquartered in Bergen, Norway.
When was Trond Mohn Research Foundation founded?
Trond Mohn Research Foundation was founded in 2004.
How many portfolio companies does Trond Mohn Research Foundation have?
Trond Mohn Research Foundation has 2 portfolio companies in Caplight's dataset.
What are some companies in Trond Mohn Research Foundation's portfolio?
Portfolio companies visible on Caplight include Pluvia Biotech, APIM Therapeutics AS.
What was Trond Mohn Research Foundation's most recent investment shown here?
Trond Mohn Research Foundation's most recent investment in this portfolio sample was in APIM Therapeutics AS in 2017.
What sectors does Trond Mohn Research Foundation focus on?
Trond Mohn Research Foundation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Trond Mohn Research Foundation focus on?
Trond Mohn Research Foundation typically invests at the Early stage.
What is Trond Mohn Research Foundation's AUM?
Trond Mohn Research Foundation's assets under management are estimated between $306.4M and $306.4M.